By replacing both CD3ζ and the CD28 co-stimulatory domain with DAP10 (the NKG2D co-stimulatory domain) in their CAR construct, two independent tumor binding events—Vγ9Vδ2 TCR signaling plus CAR signaling—were required for cell activation. The gene discussed is KLRK1; the disease is neoplasm.